FDA: Page 2
-
HHS overhaul
State attorneys general sue over ‘unconstitutional’ HHS restructuring
The lawsuit alleges the Trump administration overstepped its authority in reshaping the federal health department and asked the court to reinstate workers laid off last month.
By Susanna Vogel • May 7, 2025 -
HHS overhaul
RFK’s FDA layoffs could slow safety communications, experts warn
The mass cuts, which included communications staff, could slow public notices on medical device recalls and other safety alerts.
By Elise Reuter • May 6, 2025 -
Explore the Trendline➔
Sarah Silbiger via Getty ImagesTrendlineMedical device safety in spotlight after high profile recalls
From Philips’ massive recall of respiratory devices to ongoing health risks with breast implants, medical devices tied to patient harm have put a focus on product safety.
By MedTech Dive staff -
Edwards gains expanded TAVR label for asymptomatic patients
The medical technology company expects the new indication to increase sales in its transcatheter aortic valve replacement business with more patients becoming eligible for the treatment.
By Susan Kelly • May 5, 2025 -
Tracker
Trump policies are upending healthcare. Track the effect on the medtech industry here.
The FDA has rolled out an AI tool agency-wide, while a proposed HHS budget shows large cuts for the National Institutes of Health.
By MedTech Dive Staff • Updated June 6, 2025 -
Medtronic wins FDA approval for defibrillation lead
Omniasecure, which was authorized for placement in the heart’s right ventricle, is the world’s smallest defibrillation lead, according to Medtronic.
By Nick Paul Taylor • Updated May 5, 2025 -
ICU Medical receives FDA warning letter over infusion pumps
Inspectors found ICU Medical made multiple changes to infusion pumps without submitting premarket notifications.
By Nick Paul Taylor • April 29, 2025 -
Medtronic submits Hugo soft tissue robot for FDA approval
William Blair analyst Brandon Vazquez said 2025 could be the first year market leader Intuitive Surgical will face meaningful U.S. competition.
By Susan Kelly • April 28, 2025 -
Medtronic seeks FDA nod for insulin pump, furthering Abbott collab
Receiving FDA clearance would allow Medtronic to pair its pumps with a glucose monitor being developed for the company by Abbott.
By Elise Reuter • April 24, 2025 -
Device developers advance AI plans despite Trump uncertainty
Trump administration policies have raised questions about how the FDA will regulate AI in medical devices. AdvaMed board members think the agency should keep its leading role.
By Elise Reuter • April 24, 2025 -
FDA issues early alert for BD catheters due to leaks
BD recalled certain intravascular catheters tied to reports of 10 serious injuries after finding an increase in cracks from “material fatigue.”
By Susan Kelly • April 21, 2025 -
Precision Neuroscience receives FDA clearance for brain implant
The electrode array, which can be implanted for 30 days to map brain activity, is a component of Precision Neuroscience’s planned brain-computer interface system.
By Elise Reuter • April 21, 2025 -
Medtronic gets FDA approval to use Simplera Sync glucose sensor with insulin pumps
The updated device allows users to pair the sensor with Medtronic’s insulin pumps, and is expected to grow the company’s diabetes business.
By Elise Reuter • April 21, 2025 -
Deep Dive // HHS overhaul
HHS layoffs may be illegal, legal experts say
The federal health department sidestepped normal procedures as it laid off 10,000 employees, according to sources. One union has already filed an internal complaint, while at least two law firms are exploring suits.
By Rebecca Pifer • April 21, 2025 -
Retrieved from Ceribell on April 17, 2025
Ceribell wins FDA nod for algorithm to detect pediatric seizures
The clearance adds another feature for Ceribell to leverage as it tries to persuade hospitals to switch from conventional EEG systems.
By Nick Paul Taylor • April 21, 2025 -
Makary seeks to limit industry’s role in FDA advisory panels
Commissioner Martin Makary said the agency would, whenever possible, restrict drug company employees from participating as industry representatives on advisory committees.
By Ned Pagliarulo • Updated April 18, 2025 -
HHS overhaul
FDA cuts outlined in draft HHS budget
The draft budget would slash FDA’s budget authority, if approved by Congress.
By Elise Reuter • April 18, 2025 -
HHS overhaul
Budget draft outlines Trump’s plan to slash federal health programs
An OMB document proposes to cut the HHS budget by roughly one-third as well as eliminate several divisions and programs.
By Sydney Halleman • April 17, 2025 -
Trump tariffs
US launches probe that could set stage for pharma tariffs
The Commerce Department has begun a so-called Section 232 investigation into the national security effects of the U.S. importing pharmaceuticals and their starting materials.
By Ned Pagliarulo • Updated April 14, 2025 -
Deep Dive
A judge blocked the FDA’s plan to regulate LDTs. What now?
One attorney said the ruling “isn’t quite the stake in the heart.”
By Susan Kelly • April 16, 2025 -
Retrieved from Intuitive Surgical on April 11, 2025
Intuitive wins FDA clearance for single-port robotic surgery stapler
CFO Jamie Samath said in January that the stapler clearance would trigger the start of “broad commercial efforts” for the single-port system.
By Nick Paul Taylor • April 11, 2025 -
Dexcom nets FDA clearance for 15-day CGM
The longer wear time should improve Dexcom’s margins and help it compete with Abbott, RBC Capital Markets analyst Shagun Singh said.
By Elise Reuter • April 10, 2025 -
RFK Jr. won’t appear before Senate panel this week
HELP committee chair Bill Cassidy, R-La., had invited Kennedy to testify April 10 on the sweeping layoffs of federal health workers Kennedy ordered last month. A hearing could still take place later.
By Ned Pagliarulo • April 8, 2025 -
HHS overhaul
HHS layoffs characterized by confusion, errors
The sweeping workforce reduction that began Tuesday was made worse by mistakes and poor communication, including directions for some CMS employees to contact a director who died last year.
By Rebecca Pifer • Updated April 2, 2025 -
HHS overhaul
HHS layoffs could imperil medical device cybersecurity, Democrats say
The FDA has 3,500 jobs on the chopping block, which could hinder cybersecurity oversight, Democrats said during a House subcommittee hearing.
By Emily Olsen • April 2, 2025 -
HHS overhaul
‘Just goodbyes and crying’: CDRH hit in HHS mass layoffs
Teams working on communications and policy were cut from the agency on April 1, according to multiple FDA workers interviewed by MedTech Dive.
By Elise Reuter • April 2, 2025